Malabsorption as a Cause of Iron Treatment Failure in Infants

HaEmek Medical Center, Israel100 enrolled

Overview

Infants should receive prophylacatic iron supplementation since age 4 months till one year. Patients suffering from malabsorption, mainly Giardia infestation may develop iron deficiency resistent to further iron treatment. The purpose of this study is to assess the incidence of malabsorption in those infants and to examine the results of empiric treatment with metronidazole.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

100

Conditions

Iron Deficiency Malabsorption

Interventions

MetronidazoleDRUG

Blood testsPROCEDURE

Eligibility

Sex: ALLMin age: 6 MonthsMax age: 4 Years

Medical Language ↔ Plain English

Inclusion Criteria: * All infants referred to the Pediatric Hematology Unit because lack of response to iron treatment. Exclusion Criteria: * Patients diagnosed with specific malabsorption causes like Celiac or Cystic Fibrosis.

Locations (1)

Pediatric Hematology Unit and Pediatric Dpt B - HaEmek Medical Center

Afula, Israel

Outcomes

Primary Outcomes

Hgb level

Secondary Outcomes

Iron level

Ferritin Level

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.